INPIXON (INPX)

US45790J8678 - Common Stock

0.0527  -0.01 (-11.13%)

After market: 0.0553 +0 (+4.93%)

Fundamental Rating

2

Taking everything into account, INPX scores 2 out of 10 in our fundamental rating. INPX was compared to 86 industry peers in the IT Services industry. INPX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. INPX does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year INPX has reported negative net income.
INPX had a negative operating cash flow in the past year.
In the past 5 years INPX always reported negative net income.
INPX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

INPX's Return On Assets of -177.03% is on the low side compared to the rest of the industry. INPX is outperformed by 96.47% of its industry peers.
INPX's Return On Equity of -480.83% is on the low side compared to the rest of the industry. INPX is outperformed by 84.71% of its industry peers.
Industry RankSector Rank
ROA -177.03%
ROE -480.83%
ROIC N/A
ROA(3y)-79.01%
ROA(5y)-153.8%
ROE(3y)-124.59%
ROE(5y)-378.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of INPX (75.20%) is better than 90.59% of its industry peers.
INPX's Gross Margin has been stable in the last couple of years.
INPX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.23%
GM growth 5Y0.92%

4

2. Health

2.1 Basic Checks

INPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INPX has been increased compared to 1 year ago.
INPX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, INPX has a worse debt to assets ratio.

2.2 Solvency

INPX has an Altman-Z score of -20.29. This is a bad value and indicates that INPX is not financially healthy and even has some risk of bankruptcy.
INPX has a Altman-Z score of -20.29. This is amonst the worse of the industry: INPX underperforms 95.29% of its industry peers.
INPX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -20.29
ROIC/WACCN/A
WACC10.3%

2.3 Liquidity

INPX has a Current Ratio of 1.15. This is a normal value and indicates that INPX is financially healthy and should not expect problems in meeting its short term obligations.
INPX has a worse Current ratio (1.15) than 64.71% of its industry peers.
INPX has a Quick Ratio of 1.15. This is a bad value and indicates that INPX is not financially healthy enough and could expect problems in meeting its short term obligations.
INPX has a Quick ratio of 0.98. This is in the lower half of the industry: INPX underperforms 69.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 0.98

3

3. Growth

3.1 Past

INPX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.09%, which is quite impressive.
INPX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.32%.
The Revenue has been growing by 37.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)89.09%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q97.98%
Revenue 1Y (TTM)-14.32%
Revenue growth 3Y45.54%
Revenue growth 5Y37.58%
Revenue growth Q2Q-51.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

INPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for INPX!.
Industry RankSector Rank
Dividend Yield N/A

INPIXON

NASDAQ:INPX (3/12/2024, 8:00:02 PM)

After market: 0.0553 +0 (+4.93%)

0.0527

-0.01 (-11.13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.24M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -177.03%
ROE -480.83%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 75.2%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.15
Quick Ratio 0.98
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)89.09%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-14.32%
Revenue growth 3Y45.54%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y